Recently, a working group investigated the general opinion about an extended newborn screening for spinal muscular atrophy in 232 non-affected people (Boardman et al).
More than 80% of online interviewed persons support the screening. Main reasons were an improved medical care and expectancy of life in sick infants as well as better decision support for further pregnancies.
However, an adequate detection of affected infants is of special interest.
Publication: Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population. Mol Genet Genomic Med. 2017 Nov. doi: 10.1002/mgg3.353.